Granahan Investment Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-17,751
| Closed | -$1.05M | – | 197 |
|
|
2018
Q4 | $1.05M | Sell |
17,751
-311
| -2% | -$18.5K | 0.07% | 164 |
|
|
2018
Q3 | $2.53M | Buy |
18,062
+12,258
| +211% | +$1.72M | 0.14% | 135 |
|
|
2018
Q2 | $712K | Buy |
5,804
+792
| +16% | +$97.2K | 0.04% | 187 |
|
|
2018
Q1 | $448K | Buy |
+5,012
| New | +$448K | 0.03% | 186 |
|
|
2016
Q3 | – | Sell |
-44,170
| Closed | -$3.18M | – | 237 |
|
|
2016
Q2 | $3.18M | Buy |
44,170
+13,918
| +46% | +$1M | 0.12% | 175 |
|
|
2016
Q1 | $2.43M | Buy |
30,252
+6,179
| +26% | +$495K | 0.09% | 189 |
|
|
2015
Q4 | $1.82M | Sell |
24,073
-6,178
| -20% | -$466K | 0.06% | 216 |
|
|
2015
Q3 | $11.6M | Buy |
30,251
+3,067
| +11% | +$1.18M | 0.36% | 102 |
|
|
2015
Q2 | $11.3M | Sell |
27,184
-127
| -0.5% | -$52.8K | 0.32% | 113 |
|
|
2015
Q1 | $13M | Buy |
27,311
+18,300
| +203% | +$8.7M | 0.37% | 99 |
|
|
2014
Q4 | $3.34M | Buy |
+9,011
| New | +$3.34M | 0.1% | 180 |
|